Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense

Biotechnology and Bioengineering

Volumn 101, Issue 6, 2008, Pages 1313-1320

  Sun, Jian Bo ^a   Duan, Jin Hong ^b   Dai, Shun Ling ^b   Ren, Jun ^c   Guo, Lin ^d   Jiang, Wei ^a   Li, Ying ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c UNIVERSITY OF WYOMING   (United States)

^d NANJING UNIVERSITY   (China)

Author keywords

Antitumor property; Bacterial magnetosomes; Doxorubicin; Drug carrier; Magnetospirillum gryphiswaldense; Nano particle

Indexed keywords

ALDEHYDES; CELL PROLIFERATION; CIVIL AVIATION; DRUG DELIVERY; NANOPARTICLES; NANOSTRUCTURES; NUCLEIC ACIDS; TUMORS;

ANTITUMOR PROPERTY; BACTERIAL MAGNETOSOMES; DOXORUBICIN; DRUG CARRIER; MAGNETOSPIRILLUM GRYPHISWALDENSE; NANO-PARTICLE;

BACTERIOLOGY;

DOXORUBICIN; NANOCARRIER; NANOCRYSTAL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; MAGNETOSOME; MAGNETOSPIRILLUM; MAGNETOSPIRILLUM GRYPHISWALDENSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; HUMANS; MAGNETICS; MAGNETOSPIRILLUM; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; ORGANELLES;

BACTERIA (MICROORGANISMS); MAGNETOSPIRILLUM GRYPHISWALDENSE;

EID: 56749109518     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22011     Document Type: Article

References (39)

1. Abraham SA, McKenzie C, Masin D, Ng R, Harasym TO, Mayer LD, Bally MB. 2004. In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading. Clin Cancer Res 10:728-738.
2. Arias JL, Gallardo V, Gómez-Lopera SA, Plaza RC, Delgado AV. 2001. Synthesis and characterization of poly (ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Control Release 77:309-321.
3. Balkwill DL, Maratea D, Blakemore RP. 1980. Ultrastructure of a magnetic spirillum. J Bacteriol 141(3):1399-1408.
4. Bazylinski DA, Garratt-Reed A, Frankel RB. 1994. Electron-microscopic studies of magnetosomes in magnetotactic bacteria. Microsc Res Techniq 27:389-401.
5. Bliss C. 1935. The calculation of the dose-mortality curve. Ann Appl Biol 22:134-167.
6. Cammas S, Suzuki K, Sone C, Sakurai Y, Kataoka K, Okano T. 1997. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J Control Release 48:157-164.
7. Chitnis S, Mondal D, Agrawal KC. 2002. Zidovudine (AZT) treatment suppresses granulocyte-monocyteolony stimulating factor receptor type alpha (GM-CSFRa) gene expression in murine bone marrow cells. Life Sci 71:967-978.
8. Detlef MS, Thomas SR. 2006. Thermosensitive magnetic polymer particles as contactless controllable drug carriers. J Magn Magn Mater 302:267-271.
9. Dobson J. 2006. Magnetic nanoparticles for drug delivery. Drug Dev Res 67:55-60.
10. Garnett MC. 2001. Targeted drug conjugates: Principles and progress. Adv Drug Deliv Rev 53:171-216.
11. Gorby YA, Beveridge TJ, Blakemore RP. 1988. Characterization of the bacterial magnetosome membrane. J Bacteriol 170:834-841.
12. Grünberg K, Muller E-C, Otto A, Reszka R, Linder D, Kube M, Reinhardt R, Schüler D. 2004. Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense. Appl Environ Microb 70(2):1040-1050.
13. Hoell A, Wiedenmann A, Heyen U, Schuler D. 2004. Nanostructure and field-induced arrangement of magnetosomes studied by SANSPOL. Physica B 350:e309-313.
14. Hopkin M. 2004. Magnet-making bacteria could target tumours. Nature. DOI: 10.1038/news040906-11.
15. Hu FX, Neoh KG, Kang ET. 2006. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 27:5725-5733.
16. Jiang W, Zhao DH, Li Y, Tian JS, Wang ZF, Li JL. 2002. Submerged culture of Magnetospirillum gryphiswaldense under N2-fixing condition and regulation of activity of nitrogen fixation. Chinese Sci Bull 47(24):2095-2099.
17. Krieg UC, Walter P, Johnson AE. 1986. Photocrosslinking of the signal sequence of nascent preprolactin to the 54-kilodalton polypeptide of the signal recognition particle. Proc Natl Acad Sci USA 83:8604-8608.
18. Lai QY, Lu JZ, Ji XY. 2000. Study of preparation and properties on magnetization and stability for ferromagnetic fluids. Mater Chem Phys 66:6-9.
19. Li X, Jiang W, Sun JB, Wang GL, Guan F, Li Y. 2007. Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro. Lett Appl Microbiol 45(1):75-81.
20. Lin R, Shi Ng L, Wang C-H. 2005. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 26:4476-4485.
21. Lynn DM, Amiji MM, Langer R. 2001. pH-responsive polymer microspheres: Rapid release of encapsulated material within the range of intracellular pH. Angew Chem Int Edit 40:1707-1710.
22. Matsunaga T, Kamiya S. 1987. Use of magnetic particles isolated from magnetotactic bacteria for enzyme immobilization. Appl Environ Microb 26:328-332.
23. Matsunaga T, Ueki F, Obata K, Tajima H, Tanaka T, Takeyama H, Goda Y, Fujimoto S. 2003. Fully automated immunoassay system of endocrine disrupting chemicals using monoclonal antibodies chemically conjugated to bacterial magnetic particles. Anal Chim Acta 475:75-83.
24. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. 2004. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56(2):185-229.
25. Nagy A, Armatis P, Schally AV. 1996. High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: Structure-activity relationship of daunosamine-modified derivatives of doxorubicin. Proc Natl Acad Sci USA 93:2464-2469.
26. Nakamura N, Matsunaga T. 1993. Highly sensitive detection of allergen using bacterial magnetic particles. Anal Chim Acta 281:585-589.
27. Nakamura N, Hashimoto K, Matsunaga T. 1991. Immunoassay method for the determination of immunoglobulin G using bacterial magnetic particles. Anal Chem 63(3):268-272.
28. Ota H, Takeyama H, Nakayama H, Katoh T, Matsunaga T. 2003. SNP detection in transforming growth factor-β1 gene using bacterial magnetic particles. Biosens Bioelectron 18:683-687.
29. Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003. Application of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:167-181.
30. Pollakis G, Goormaghtigh E, Ruysschaert J-M. 1983. Role of the quinone structure in the mitochondrial damage induced by antitumor anthracyclines. FEBS Lett 155(2):267-272.
31. Sarikaya M. 1994. An introduction to biomimetics: A structural viewpoint. Microsc Res Techniq 27:360-375.
32. Schüler D, Frankel RB. 1999. Bacterial magnetosomes: Microbiology, biomineralization and biotechnological applications. Appl Environ Microb 52:464-473.
33. Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. New Engl J Med 339(13):900-905.
34. Singal PK, Iliskovic N, Li T, Kumar D. 1997. Adriamycin cardiomyopathy: Pathophysiology and prevention. FASEB J 11:931-936.
35. Sun JB, Jiang W, Li Y, Zhang YD, Li JL. 2007. The magnetosomes of magnetotactic bacteria may be used as drug-carriers for targeted therapy. Microbiology 34(1):165-168.
36. Takeyama H, Yamazawa A, Nakamura C, Matsunaga T. 1995. Application of bacterial magnetic particles as novel DNA carriers for ballistic transformation of a marine cyanobacterium. Biotechnol Techniq 9(5):355-360.
37. Torchilin VP. 2000. Drug targeting. Eur J Pharm Sci 11(2):S81-S91.
38. Widder KJ, Senyei AE, Scarpelli DG. 1978. Magnetic microspheres: A model system for site specific drug delivery in vivo. Proc Soc Exp Biol Med 158:141-146.
39. Yang J, Park SB, Yoon H-G, Huh YM, Haam S. 2006. Preparation of poly ε-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 324:185-190.